Shumin Qiu1, Chongmin Jiang2. 1. School of Sport Economics and Management, Central University of Finance and Economics, 39 South College Road, Haidian District, Beijing, 100081, People's Republic of China. qiusm0066@126.com. 2. Youth Sports Research Center, China Institute of Sport Science, Beijing, People's Republic of China.
Abstract
BACKGROUND: Some studies have investigated the association between soy and isoflavones consumption and breast cancer survival, but the results are far from conclusive. Accordingly, we performed a systematic review and meta-analysis to explore this issue. METHODS: We performed a comprehensive search of Web of Science, PubMed, and Embase from inception to January 2018. The summary hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using a random effects model. RESULTS: A total of 12 articles were included, which reported overall survival (OS), breast cancer specific survival (BCSS), and recurrence in 5770, 2386, and 1500 cases, respectively, among 37,275 women with breast cancer. The summary HR (95% CI) for the association (highest vs. lowest) of pre-diagnosis soy and isoflavones consumption with OS and BCSS was 0.84 (0.71-0.98) and 0.89 (0.74-1.07), respectively. Stratified analyses suggested that the reduced OS was more easily detected in studies that focused on post-menopausal patients. No significant association was found between post-diagnosis soy and isoflavones consumption with OS and BCSS, with summary HRs (95% CIs) of 0.80 (0.62-1.04) and 0.83 (0.64-1.07), respectively. Pre- and post-diagnosis soy isoflavones consumption were associated with reduced risk of recurrence. CONCLUSION: This study provides limited evidence that pre-diagnosis soy and isoflavones intake is associated with a small reduction in post-menopausal breast cancer OS.
BACKGROUND: Some studies have investigated the association between soy and isoflavones consumption and breast cancer survival, but the results are far from conclusive. Accordingly, we performed a systematic review and meta-analysis to explore this issue. METHODS: We performed a comprehensive search of Web of Science, PubMed, and Embase from inception to January 2018. The summary hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using a random effects model. RESULTS: A total of 12 articles were included, which reported overall survival (OS), breast cancer specific survival (BCSS), and recurrence in 5770, 2386, and 1500 cases, respectively, among 37,275 women with breast cancer. The summary HR (95% CI) for the association (highest vs. lowest) of pre-diagnosis soy and isoflavones consumption with OS and BCSS was 0.84 (0.71-0.98) and 0.89 (0.74-1.07), respectively. Stratified analyses suggested that the reduced OS was more easily detected in studies that focused on post-menopausal patients. No significant association was found between post-diagnosis soy and isoflavones consumption with OS and BCSS, with summary HRs (95% CIs) of 0.80 (0.62-1.04) and 0.83 (0.64-1.07), respectively. Pre- and post-diagnosis soy isoflavones consumption were associated with reduced risk of recurrence. CONCLUSION: This study provides limited evidence that pre-diagnosis soy and isoflavones intake is associated with a small reduction in post-menopausal breast cancer OS.
Entities:
Keywords:
Breast cancer; Breast cancer specific survival; Overall survival; Soy isoflavone
Authors: Stephen Barnes; Jeevan Prasain; Tracy D'Alessandro; Ali Arabshahi; Nigel Botting; Mary Ann Lila; George Jackson; Elsa M Janle; Connie M Weaver Journal: Food Funct Date: 2011-05-09 Impact factor: 5.396
Authors: Neela Guha; Marilyn L Kwan; Charles P Quesenberry; Erin K Weltzien; Adrienne L Castillo; Bette J Caan Journal: Breast Cancer Res Treat Date: 2009-02-17 Impact factor: 4.872
Authors: Elisa V Bandera; Melony King; Urmila Chandran; Lisa E Paddock; Lorna Rodriguez-Rodriguez; Sara H Olson Journal: BMC Womens Health Date: 2011-09-23 Impact factor: 2.809
Authors: Pan Pan Wang; Xin Song; Xue Ke Zhao; Meng Xia Wei; She Gan Gao; Fu You Zhou; Xue Na Han; Rui Hua Xu; Ran Wang; Zong Min Fan; Jing Li Ren; Xue Min Li; Xian Zeng Wang; Miao Miao Yang; Jing Feng Hu; Kan Zhong; Ling Ling Lei; Liu Yu Li; Yao Chen; Ya Jie Chen; Jia Jia Ji; Yuan Ze Yang; Jia Li; Li Dong Wang Journal: Front Oncol Date: 2022-01-28 Impact factor: 6.244